• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺导管腺癌患者Whipple术后成像:与总生存期的关联:一项多变量分析

Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis.

作者信息

Elmi Azadeh, Murphy Janet, Hedgire Sandeep, McDermott Shaunagh, Abtahi Seyed-Mahdi, Halpern Elkan, Fernandez-Del Castillo Carlos, Harisinghani Mukesh

机构信息

Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, 55 Fruit St., White 270, Boston, MA, 02114, USA.

Division of Hematology and Oncology, Massachusetts General Hospital, 55 Fruit St., Boston, MA, 02114, USA.

出版信息

Abdom Radiol (NY). 2017 Aug;42(8):2101-2107. doi: 10.1007/s00261-017-1099-2.

DOI:10.1007/s00261-017-1099-2
PMID:28293721
Abstract

PURPOSE

To compare the survival outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) who had regular imaging surveillance with those who had clinical follow-up after Whipple.

METHOD

We identified 229 patients, who underwent Whipple for resection of PDAC from 2005 to 2011, and had regular postoperative clinical follow-up at our hospital. Patients were retrospectively selected for two follow-up groups: imaging surveillance (IS) defined as routine imaging at scheduled intervals, vs. clinical (C) defined as imaging triggered by either change in clinical status or change in CA19-9. Follow-up was obtained through the hospital and Cancer Data Registry records. Survival was calculated from the date of surgery to death or last follow-up, with data censored as of March 13, 2013. Kaplan-Meier survival curves were compared using the log-rank test, and Cox regression models were used for multivariate analysis.

RESULTS

Patients were followed for a mean period of 24.35 ± 2.56 months. IS-group underwent significantly more imaging (4.41 vs. 2.08 scans/year). The most frequent imaging was CT of chest and abdomen at 3-4 month interval. Univariate associations with overall survival were detected with post-Whipple ECOG status, T-stage, N-stage, tumor grade, surgical margin, recurrence, and IS. In multivariate analysis, grade, ECOG status, and recurrence were independent predictors of survival. Also, our predictor of interest, IS, was highly associated with longer survival in multivariate modeling (median overall survival, 30.4±3.85 (IS-group) vs. 17.1 ± 2.42 (C-groups) month, log-rank p = 0.002).

CONCLUSION

Routine imaging surveillance was associated with prolonged overall survival post-Whipple in a multivariate model. This is a hypothesis-generating finding that should be studied prospectively and could ultimately impact surveillance guidelines.

摘要

目的

比较接受胰十二指肠切除术的胰腺导管腺癌(PDAC)患者中,进行定期影像监测与临床随访者的生存结局。

方法

我们纳入了2005年至2011年间接受胰十二指肠切除术以切除PDAC且在我院进行定期术后临床随访的229例患者。患者被回顾性分为两个随访组:影像监测(IS)组,即按预定间隔进行常规影像检查;临床随访(C)组,即根据临床状态变化或CA19-9变化触发影像检查。通过医院记录和癌症数据登记处获取随访信息。从手术日期计算至死亡或最后一次随访的生存时间,数据截至2013年3月13日进行截尾。采用对数秩检验比较Kaplan-Meier生存曲线,并使用Cox回归模型进行多因素分析。

结果

患者的平均随访时间为24.35±2.56个月。IS组进行的影像检查显著更多(4.41次/年 vs. 2.08次/年)。最常见的影像检查是每隔3 - 4个月进行一次胸部和腹部CT检查。与总生存相关的单因素分析包括胰十二指肠切除术后的美国东部肿瘤协作组(ECOG)状态、T分期、N分期、肿瘤分级、手术切缘、复发情况以及影像监测。多因素分析中,分级、ECOG状态和复发是生存的独立预测因素。此外,我们感兴趣的预测因素影像监测,在多因素模型中与更长的生存高度相关(总生存中位数,IS组为30.4±3.85个月,C组为月17.1±2.42个月,对数秩检验p = 0.002)。

结论

在多因素模型中,常规影像监测与胰十二指肠切除术后的总生存延长相关。这是一个有待前瞻性研究验证的发现,最终可能会影响监测指南。

相似文献

1
Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis.胰腺导管腺癌患者Whipple术后成像:与总生存期的关联:一项多变量分析
Abdom Radiol (NY). 2017 Aug;42(8):2101-2107. doi: 10.1007/s00261-017-1099-2.
2
Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.术前多排 CT 对胰外神经丛或十二指肠侵犯的诊断与胰十二指肠切除术治疗胰腺腺癌后的术后生存降低有关:初步经验及其对患者护理的影响。
Radiology. 2016 Dec;281(3):816-825. doi: 10.1148/radiol.2016152790. Epub 2016 Jul 20.
3
Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.胰导管腺癌根治性手术后的随访:无症状复发与生存改善相关。
Eur J Surg Oncol. 2013 Jun;39(6):559-66. doi: 10.1016/j.ejso.2013.02.020. Epub 2013 Mar 14.
4
Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.胰头导管腺癌行胰十二指肠部分切除术的长期结果:25年经验
World J Surg. 2003 Mar;27(3):324-9. doi: 10.1007/s00268-002-6659-z. Epub 2003 Feb 27.
5
Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.胰十二指肠切除术在一部分老年胰腺导管腺癌患者中是合理的:基于人群的 4283 例患者回顾性队列研究。
Int J Surg. 2018 May;53:262-268. doi: 10.1016/j.ijsu.2018.03.054. Epub 2018 Mar 29.
6
Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.胰腺癌患者术前和术后CA19-9、SPan-1及DUPAN-II水平对预后影响的比较
Pancreatology. 2017 Jan-Feb;17(1):95-102. doi: 10.1016/j.pan.2016.10.004. Epub 2016 Oct 11.
7
Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.影响胰头腺癌行门静脉切除术患者预后的因素。
Eur J Surg Oncol. 2012 Jan;38(1):72-9. doi: 10.1016/j.ejso.2011.08.134. Epub 2011 Nov 3.
8
Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.开发和验证用于预测胰腺导管腺癌患者手术后生存的新型列线图。
Cancer Med. 2020 May;9(10):3353-3370. doi: 10.1002/cam4.2959. Epub 2020 Mar 17.
9
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.胰十二指肠切除术治疗导管腺癌时切缘受累的预后价值:一项法国前瞻性多中心研究的更新结果。
Ann Surg. 2017 Nov;266(5):787-796. doi: 10.1097/SLA.0000000000002432.
10
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma?手术等候名单是否会影响可切除性胰腺导管腺癌的病理及生存结果?
HPB (Oxford). 2018 May;20(5):411-417. doi: 10.1016/j.hpb.2017.10.017. Epub 2017 Nov 27.

引用本文的文献

1
Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma.胰腺腺癌切除术后的常规影像学检查或症状性随访
JAMA Surg. 2025 Jan 1;160(1):74-84. doi: 10.1001/jamasurg.2024.5024.
2
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.使用基于复发监测策略的 RADAR-PANC 对胰腺导管腺癌切除术后的疾病复发进行检测:一项按照队列内试验设计的国际随机对照试验方案。
Trials. 2024 Jun 20;25(1):401. doi: 10.1186/s13063-024-08223-5.
3
GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma.
高尔基体磷蛋白3通过与STIP1相互作用并调节胰腺导管腺癌中的端粒酶活性来促进癌症生长。
Front Oncol. 2020 Oct 2;10:575358. doi: 10.3389/fonc.2020.575358. eCollection 2020.
4
Detection of recurrent pancreatic cancer: value of second-opinion interpretations of cross-sectional images by subspecialized radiologists.检测复发性胰腺癌:由放射科亚专科医生进行横断面图像二次解读的价值。
Abdom Radiol (NY). 2019 Feb;44(2):586-592. doi: 10.1007/s00261-018-1765-z.